Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ana Vidović, Gradimir Janković, Milica Čolović, Dragica Tomin, Maja Peruničić, Jelena Bila, Olivera Marković & Darinka Bošković. (2008) The proto-oncogene expression varies over the course of chronic myeloid leukemia. Hematology 13:1, pages 34-40.
Read now
Read now
Articles from other publishers (25)
Naranie Shanmuganathan, Bradley Chereda & Junia V. Melo. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
17
36
.
Fumio Kasai, Hiroya Asou, Midori Ozawa, Kazuhiko Kobayashi, Hiroyuki Kuramitsu, Motonobu Satoh, Arihiro Kohara, Yasuhiko Kaneko & Machiko Kawamura. (2020) Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations. Human Cell 33:3, pages 868-876.
Crossref
Crossref
Mingwei Jin, Chengmin Xuan, Jizhao Gao, Rui Han, Shumei Xu, Lei Wang, Yuan Wang, Kunpeng Shi, Sunil Rauniyar & Qi An. (2018) Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia. Medicine 97:45, pages e13131.
Crossref
Crossref
Masumeh Maleki Behzad, Saeid Shahrabi, Kaveh Jaseb, Jessika Bertacchini, Neda Ketabchi & Najmaldin Saki. (2018) Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response. Biochemical Genetics 56:3, pages 149-175.
Crossref
Crossref
Jiawei Yin, Fan Zhang, Huiquan Tao, Xiao Ma, Guangsong Su, Xiaoli Xie, Zhongjuan Xu, Yanwen Zheng, Hong Liu, Chao He, Zhengwei Jenny Mao, Zhiwei Wang, Weirong Chang, Robert Peter Gale, Depei Wu & Bin Yin. (2016) BCL11A expression in acute phase chronic myeloid leukemia. Leukemia Research 47, pages 88-92.
Crossref
Crossref
Bradley Chereda & Junia V. Melo. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
17
39
.
Bradley Chereda & Junia V. Melo. (2015) Natural course and biology of CML. Annals of Hematology 94:S2, pages 107-121.
Crossref
Crossref
Khaldon Bodoor, Yazan Haddad, Asem Alkhateeb, Abdullah Al-Abbadi, Mohammad Dowairi, Ahmad Magableh, Nazzal Bsoul & Abdulhameed Ghabkari. (2014) DNA Hypermethylation of Cell Cycle (p15 and p16) and Apoptotic (p14, p53, DAPK and TMS1) Genes in Peripheral Blood of Leukemia Patients. Asian Pacific Journal of Cancer Prevention 15:1, pages 75-84.
Crossref
Crossref
William Stevenson & Guillermo Garcia-Manero. 2013. Childhood Leukemias. Childhood Leukemias
239
256
.
Susan Branford, Junia V. Melo & Timothy P. Hughes. (2009) Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?. Blood 114:27, pages 5426-5435.
Crossref
Crossref
Alex J Tipping & Junia V Melo. (2004) Comparative gene expression profile of p185Bcr-Abl versus p210Bcr-Abl expressing cells. Leukemia Research 28:3, pages 219-220.
Crossref
Crossref
Ta-Chih Liu, Sheng-Fung Lin, Jan-Gowth Chang, Ming-Yu Yang, Shih-Ya Hung & Chao-Sung Chang. (2003)
Epigenetic alteration of the
SOCS1
gene in chronic myeloid leukaemia
. British Journal of Haematology 123:4, pages 654-661.
Crossref
Crossref
. 2003. Genetic Recombination in Cancer. Genetic Recombination in Cancer
170
236
.
AS Shet, BN Jahagirdar & CM Verfaillie. (2002) Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 16:8, pages 1402-1411.
Crossref
Crossref
Darren R. Hodgson, Carole A. Foy, Maxine Partridge, Stelios Pateromichelakis & Neil J. Gibson. (2002) Development of a Facile Fluorescent Assay for the Detection of 80 Mutations Within the p53 Gene. Molecular Medicine 8:5, pages 227-237.
Crossref
Crossref
H Yamaguchi, K Inokuchi, Y Sakuma & K Dan. (2001) Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia. Leukemia 15:11, pages 1729-1734.
Crossref
Crossref
Darren R Hodgson, Simon J Clayton, Fiona Girdler, Ian Brotherick, Brian Shenton, David Browell, Mary Stuart, Jayne C Fox, Peter Ceuppens, Carole A Foy, David Whitcombe & Neil J Gibson. (2001) ARMS™ Allele-specific Amplification-based Detection of Mutant p53 DNA and mRNA in Tumors of the Breast. Clinical Chemistry 47:4, pages 774-778.
Crossref
Crossref
Susan M Gribble, Ian Roberts, Colin Grace, Kathryn M Andrews, Anthony R Green & Elizabeth P Nacheva. (2000) Cytogenetics of the Chronic Myeloid Leukemia-Derived Cell Line K562. Cancer Genetics and Cytogenetics 118:1, pages 1-8.
Crossref
Crossref
Kerim Kaban, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Jorge Cortes, Francis J. Giles, Sherry Pierce & Maher Albitar. (2000) Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia. Cancer 88:3, pages 570-576.
Crossref
Crossref
HG Drexler, S Fombonne, Y Matsuo, Z-B Hu, H Hamaguchi & CC Uphoff. (2000) p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?. Leukemia 14:1, pages 198-206.
Crossref
Crossref
Jun Miyauchi, Minoru Asada, Yukiko Tsunematsu, Yasuhiko Kaneko, Seiji Kojima & Shuki Mizutani. (2001) Abnormalities of the p53 gene in juvenile myelomonocytic leukaemia. British Journal of Haematology 106:4, pages 980-986.
Crossref
Crossref
Francis J. Giles, Hagop M. Kantarjian, Jorge Cortes, Deborah A. Thomas, Moshe Talpaz, Taghi Manshouri & Maher Albitar. (1999) Multidrug resistance protein expression in chronic myeloid leukemia. Cancer 86:5, pages 805-813.
Crossref
Crossref
Stefan Faderl, Moshe Talpaz, Zeev Estrov, Susan O'Brien, Razelle Kurzrock & Hagop M. Kantarjian. (1999) The Biology of Chronic Myeloid Leukemia. New England Journal of Medicine 341:3, pages 164-172.
Crossref
Crossref
S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni & J. M. Phang. (1999) Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice. JNCI Journal of the National Cancer Institute 91:3, pages 215-225.
Crossref
Crossref
M. R. Hilleman. 1998. Genes and Environment in Cancer. Genes and Environment in Cancer
345
362
.